Baseline serum cholestanol as predictor of recurrent coronary events in subgroup of Scandinavian simvastatin survival study

British Medical Journal

Volumn 316, Issue 7138, 1998, Pages 1127-1130

  Miettinen, Tatu A ^a   Gylling, Helena ^a   Strandberg, Timo ^a   Sarna, Seppo ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTANOL; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; SIMVASTATIN; TRIACYLGLYCEROL;

ARTICLE; BLOOD LEVEL; BODY MASS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY RISK; FINLAND; HUMAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REGRESSION ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0032507494     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.316.7138.1127     Document Type: Article

References (24)

1. Scandinavian Simvastatin Survival Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian simvastatin survival study (4S). Lancet 1994;344:1383-9.
2. Scandinavian Simvastatin Survival Study Group. Baseline serum cholesterol and treatment effect in the Scandinavian simvastatin survival study (4S). Lancet 1995;345:1274-5.
3. Miettinen TA. Detection of changes in human cholesterol metabolism. Ann Clin Res 1970;2:300-20.
4. Miettinen TA. Serum methyl sterols and their distribution between major lipoprotein fractions in different clinical conditions. Ann Clin Res 1971;3:264-71.
5. Vuoristo M, Miettinen TA. Serum cholesterol precursor sterols in coeliac disease: effects of gluten-free diet and cholestyramine. Gut 1986;27:1312-9.
6. Gylling H, Miettinen TA. Serum noncholesterol sterols related to cholesterol metabolism in familial hypercholesterolemia. Clin Chim Acta 1988;178:41-50.
7. Färkkilä MA, Tilvis RS, Miettinen TA. Raised plasma cholesterol precursors in patients with gut resections. Gut 1988;29:188-95.
8. Kempen HJM, Glatz JFC, Leuven JAG, Voort van der HA, Katan MB, Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans. J Lipid Res 1988;29:1149-55.
9. Miettinen TA, Tilvis RS, Kesäniemi YA. Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol 1990;131:20-31.
10. Björkhem I, Miettinen IA, Reihner E, Ewerth S, Angelin B, Einarsson K. Correlation between serum levels of some cholesterol precursors and activity of HMG-CoA reductase in human liver. J Lipid Res 1987;28:1137-43.
11. Tilvis RS, Miettinen TA. Serum plant sterols and their relation to cholesterol absorption. Am J Clin Nutr 1986;13:92-7.
12. Scandinavian Simvastatin Survival Study Group. Design and baseline results of the Scandinavian simvastatin survival study of patients with stable angina and/or previous myocardial infarction. Am J Cardiol 1993;71:393-400.
13. Miettinen IA, Koivisto P. Non-cholesterol sterols and bile acid production in hypercholesterolemic patients with ileal by-pass. In: Paumgartner G, Stiehl A, Gerok W, eds. Bile acids and cholesterol in health and disease. Lancaster, Pennsylvania: MTP. 1983:183-7.
14. Miettinen TA. Cholesterol metabolism during ketocotiazole treatment in man. J Lipid Res 1988;29:13-51.
15. Gardner MJ, Altman DG. Confidence interval analysis (CIA): microcomputer program manual and disk. London: BMJ Publishing, 1989.
16. Dixon WJ, ed. BMDP statistical software manual. Vols 1-2. Los Angeles: Berkeley University of California Press, 1992.
17. Miettinen TA, Strandberg T, Vanhanen H, Gylling H, for the 4S Group. Non-cholesterol serum sterols in Scandinavian simvastatin survival study. In: Gotto Jr AM, Paoletti R, Smith LC, Catapano AI, Jackson AS, eds. Drugs affecting lipid metabolism. Risk factors and future directions. Dordrecht: Kluwer Academic Publishers, 1996. (Medical Science Symposium series, No 10:173-6.)
18. Björkhem I, Skrede S. Familial diseases with storage of sterols other than cholesterol: cerebrotendinous xanthomatosis and phytosterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited disease. 6th ed. New York: McGraw-Hill, 1989:1283-302.
19. Glueck CJ, Speirs J, Tracy T, Streicher P, Illig E, Vandegrift J. Relationships of serum plant sterols (phytosterols) and cholesterol in 595 hypercholesterolemic subjects, and familial aggregation of phytosterols, cholesterol, and premature coronary heart disease in hyperphytosterolemic prohands and their first-degree relatives. Metabolism 1991;40:842-8.
20. Miettinen TA, Kesäniemi YA. Cholesterol absorption: regulation of cholesterol synthesis and elimination and within-population variations of serum cholesterol levels. Am J Clin Nutr 1989;49:629-35.
21. Miettinen TA, Tilvis RS, Kesäniemi YA. Serum cholestanol and plant sterol levels in relation to cholesterol metabolism in middle-aged men. Metabolism 1989;38:136-40.
22. Miettinen TA, Puska P, Gylling H, Vanhanen H, Vartiainen E. Serum cholesterol lowering by sitostanol ester margarine in a mildly hypercholesterolemic random population. N Engl J Med 1995;333:1308-12.
23. Gylling H, Miettinen TA. Effects of inhibiting cholesterol absorption and synthesis on cholesterol and lipoprotein metabolism in hypercholesterolemic non-insulin-dependent diabetic men. J Lipid Res 1996;37:1776-85.
24. Gylling H, Miettinen TA. Sitostanolester added to long term simvastatin treatment of coronary patients with low and high basal cholesterol absorption. Atherosclerosis 1997;134:157.